Cj Cheiljedang Corporation

Immunomet Therapeutics Inc.

Lg Electronics Inc.

Hyundai Motor Company

Kia Motors Corporation

Kia Corporation

Sk Innovation Co., Ltd.

Sk on Co., Ltd.

Cheiljedang Corp.

Hanall Biopharma Co., Ltd.

Jctech Co., Ltd.

Kj Technology Co., Ltd.

Angelswing Inc

Lg Energy Solution, Ltd.

Ji Sun Lee

Sung Wuk Kim

Yong Eun Kim

Chang Hee Min

Kwang Ho Lee

Hye Jin Heo

Young Bin Hwang

Hyo Jin Kim

Chang Il Seo

Hong Bum Lee

Sung Soo Jun

Keun Chul Lee

Min Woo Kang

Hyung Joon Kim

Hyun Ah Kim

Young Woo Lee

Jae Kap Jeong

Ki Yong Cheong

So Young Kim

Sang Jo Lim

Soo An Shin

Sung Hoo Jhon

Keun Cheol Lee

Jin Woo Park

Seon Chae Na

Young Jun Kim

Sang Min Park

Chan Ho Jung

Soo Hyun Moon

Ji Hoon Choi

Jin Sook Chang

Sang Jun Kim

Sang Bok Kim

Seok Myung Lee

Young Jae Lee

Ji Hyun Park

Suk Won Hong

Kwang Ho Jeong

Sung Hak Hong

Ji Hea Kim

Yeon Jung Song

Hyun Won Bae

Ju Hoon Oh

Lan Huh

Jung Moon Sung

Duck Kim

Se Hwan Park

Hong Woo Kim

Eun Sung Koh

Ji Ae Kook

Byung Kyu Oh

Young Woong Kim

Chul Ha Kim

Sang Hye Shin

Woong Cho

Hyoung Joon Kim

Seung Bin Lee

Jae Yeong Ju

Hyeong Pyo Hong

Su Yon Kwon

Sang Hee Yoo

Jun Yong Kim

Dong Eun Chang

Jong Oh Kim

Min Jeong Kim

Do Hyun Kwon

Ho Jae Lee

Jun Young Jang

You Sook Eun

Eun Ji Koh

Eun Kyoung Shin

Soon Im Lee

Chang Ii Seo

Jae Young Choi

Seung Deok Seo

Juno Jang

Min Jae Shin

Kook Hwan Oh

Kyung Don Ju

Hye Soun Eum

Won Nyoung Park

Joon Mo Yang

Seo-il Kim

Mi Jeong Kim

Jong Ook Kim

An anode active material for a secondary battery includes an anode current collector, and an anode active material layer on at least one surface of the anode current collector. The anode active material layer includes an anode active material and an anode binder. The anode active material includes a composite particle that includes a silicon-based active material particle and a solid electrolyte interphase (SEI) layer formed on at least a portion of a surface of the silicon-based active material particle. An F-density defined by Equation 1 is 23% or less.

Anode for lithium secondary battery, method of manufacturing the same and lithium secondary battery including the same

The present disclosure provides a reclining seat assembly device for a vehicle in which a guide pin mounted on a mounting frame of a leg unit is inserted into a guide hole formed in a floor panel so as to be prevented from being separated from the guide hole during reclining of a seatback, whereby the reclining seat is prevented from deviating from a predetermined position on the floor panel and subsequent processes for assembling the reclining seat can be smoothly carried out.

Device for assembling reclining seat of vehicle

The present disclosure relates to a variant of cAMP receptor protein ofwith alanine at position 35, a microorganism including the same, and a method of producing an L-amino acid using the same.

Camp receptor protein variant and method of producing L-amino acid using the same

An apparatus for providing drone data provides a method of matching a user who needs drone data of a certain area with at least one provider capable of providing drone data of a part or the entirety of the certain area.

Method and apparatus for providing drone data by matching user with provider

The present invention relates to a guanidine compound and a use thereof, and more specifically, to a guanidine derivative showing excellent effects of inhibiting cancer cell proliferation, cancer metastasis, and cancer recurrence; a preparation method thereof; and a pharmaceutical composition containing the same as an active ingredient. Compared to existing drugs, the guanidine derivative according to the present invention shows excellent effects of inhibiting cancer cell proliferation, cancer metastasis, and cancer recurrence even with small doses, and may thus be effectively used in preventing or treating various cancers such as uterine cancer, breast cancer, stomach cancer, brain cancer, rectal cancer, colorectal cancer, lung cancer, skin cancer, blood cancer, liver cancer, etc., inhibiting cancer cell proliferation and cancer metastasis.

Biguanide compound and use thereof

The present disclosure relates to modified homoserine dehydrogenase and a method for producing a homoserine-derived L-amino acid using the same.

Nucleic acid encoding a modified homoserine dehydrogenase

A nucleic acid molecule comprising a variant inc coding strand is disclosed as a regulator of plasmid copy number. Also disclosed is a replicon comprising the nucleic acid molecule, a promoter, and an origin of replication. Also disclosed is a vector comprising the replicon. Also disclosed is a recombinant microorganism comprising the vector.

Nucleic acid molecules comprising a variant inc coding strand

Provided are a cAMP receptor protein variant and coding sequence, a microorganism including the same, and a method of producing a L-amino acid using the same.

cAMP receptor protein variant, coding sequence and method of producing L-amino acid using the same

The present invention relates to guanidine compounds for inhibiting mitochondrial oxidative phosphorylation (OXPHOS) and use thereof. More specifically, the present invention relates to a pharmaceutical composition for preventing or treating a OXPHOS-related disease, particularly cancer, by inhibiting mitochondrial oxidative phosphorylation and reprogramming cellular metabolism.

Guanidine compounds and use thereof

A nucleic acid molecule comprising a variant rpoC coding sequence is disclosed. The variant rpoC coding sequence encodes a variant RpoC which regulates copy number of a plasmid. Also disclosed are a recombinant microorganism comprising the nucleic acid molecule, a method for regulating copy number of a subject vector in the recombinant microorganism, and a method for making a target product by use of the recombinant microorganism.

Nucleic acid molecules comprising a variant RpoC coding sequence

The present invention relates to a novel variant RNA polymerase sigma factor 70 (&#x3b4;) polypeptide, a polynucleotide encoding the same, a microorganism containing the polypeptide, and a method for producing L-threonine by using the microorganism.

Microorganism with improved L-threonine producing capability, and method for producing L-threonine by using the same

Modified homoserine dehydrogenase and method for producing homoserine or L-amino acid derived from homoserine using the same

The present invention relates to a novel variant RNA polymerase sigma factor 70 (&#x3c3;) polypeptide, a polynucleotide encoding the same, a microorganism containing the polypeptide, and a method for producing L-threonine by using the microorganism.

Modified RNA polymerase sigma factor 70 polypeptide

A lumbar support apparatus for a vehicle seat includes: a seatback frame having an adjustable inclination angle; an operating mechanism disposed at an upper portion of the seatback frame, the operating mechanism including a connector generating an operating force in a vertical direction by being in contact with a fixture fixed to a vehicle body when the inclination angle of the seatback frame is adjusted; and a support mechanism disposed at a lower portion of the seatback frame, connected to the connector, receiving the operating force generated from the connecting mechanism, and configured to slide in a front and rear direction depending on an application direction of the operating force, such that when the inclination angle of the seatback frame is adjusted to be directed rearward, the support mechanism receives the operating force of the operating mechanism and is advanced forward to support a waist of an occupant.

Lumbar support apparatus for vehicle seat

The present invention relates to a novel variant RNA polymerase sigma factor 70 (&#x3c0;) polypeptide, a polynucleotide encoding the same, a microorganism containing the polypeptide, and a method for producing L-threonine by using the microorganism.

Growing community of inventors

Incheon, South Korea

Ji Sun Lee